Barclays’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 4606 |
|
|
2025
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 4584 |
|
|
2024
Q3 | – | Sell |
-19,261
| Closed | -$67K | – | 4456 |
|
|
2024
Q2 | $67K | Sell |
19,261
-3,816
| -17% | -$13.3K | ﹤0.01% | 3560 |
|
|
2024
Q1 | $122K | Hold |
23,077
| – | – | ﹤0.01% | 3568 |
|
|
2023
Q4 | $119K | Buy |
+23,077
| New | +$119K | ﹤0.01% | 3673 |
|
|
2023
Q2 | – | Sell |
-3,504
| Closed | -$13K | – | 4426 |
|
|
2023
Q1 | $13K | Buy |
3,504
+1,652
| +89% | +$6.13K | ﹤0.01% | 4054 |
|
|
2022
Q4 | $6K | Buy |
1,852
+1,577
| +573% | +$5.11K | ﹤0.01% | 4194 |
|
|
2022
Q3 | $1K | Sell |
275
-51
| -16% | -$185 | ﹤0.01% | 4581 |
|
|
2022
Q2 | $9K | Sell |
326
-724
| -69% | -$20K | ﹤0.01% | 4361 |
|
|
2022
Q1 | $40K | Sell |
1,050
-6,800
| -87% | -$259K | ﹤0.01% | 4089 |
|
|
2021
Q4 | $459K | Buy |
7,850
+5,203
| +197% | +$304K | ﹤0.01% | 2569 |
|
|
2021
Q3 | $218K | Buy |
2,647
+1,840
| +228% | +$152K | ﹤0.01% | 2944 |
|
|
2021
Q2 | $76K | Buy |
807
+135
| +20% | +$12.7K | ﹤0.01% | 3229 |
|
|
2021
Q1 | $43K | Buy |
+672
| New | +$43K | ﹤0.01% | 3552 |
|